Marc Roth

Saint Luke's Hospital

Papers

1

Total Citations

9

H-Index

1

About

Marc Roth is a clinician-researcher whose work sits at the intersection of precision oncology and advanced surgical techniques, with a particular focus on colorectal and esophageal malignancies. His most cited study, a 2023 case report, documents the first known response to osimertinib in a colorectal cancer patient harboring an EGFR T790M mutation—a finding that challenges conventional tissue-specific treatment paradigms and opens new avenues for targeted therapy in colorectal cancer. This work, which has already garnered 9 citations, demonstrates Roth’s ability to translate molecular insights into actionable clinical strategies. Beyond targeted therapy, Roth is a proponent of minimally invasive surgery, contributing to the growing evidence base for laparoscopic, thoracoscopic, and robotic approaches in esophageal cancer management. His research addresses the steep learning curve of these complex procedures while highlighting their advantages in visualization and patient recovery. Roth’s dual expertise in molecular profiling and surgical innovation positions him as a bridge between bench and bedside, making his work particularly relevant for students and researchers interested in the convergence of genomics and operative technique in gastrointestinal oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
9
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Response to osimertinib in a colorectal cancer patient with an <i>EGFR</i> T790M mutation: A case report
9 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Saint Luke's Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago